Weight change associated With telotristat ethyl in the treatment of carcinoid syndrome.

Martin O'Weickert,Gregory Kaltsas,Dieter Hörsch,Pablo Lapuerta,Marianne Pavel,Juan W Valle,Martyn Caplin,Emily K. Bergsland,Pamela L. Kunz,Lowell B. Anthony,Enrique Grande,Kjell Öberg,Staffan Welin,Richard R. P. Warner,Catherine Lombard Bohas,Rosanna Fleming,Ashwin Kittur,Karie Arnold,Qi M. Yang,Matthew H. Kulke

Weight change associated With telotristat ethyl in the treatment of carcinoid syndrome.

2018

Efficacy and Safety of Telotristat Ethyl in Patients With Carcinoid Syndrome Inadequately Controlled by Somatostatin Analogs : Analysis of the Completed TELESTAR Extension Period

Keywords:

Internal medicine
Endocrinology
Diabetes mellitus
Biology
Carcinoid syndrome
Telotristat ethyl
weight change

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations